Bioorganic and Medicinal Chemistry p. 1863 - 1872 (2014)
Update date:2022-07-30
Topics: Molecular Hybridization
Chen, Wenmin
Zhan, Peng
Rai, Diwakar
De Clercq, Erik
Pannecouque, Christophe
Balzarini, Jan
Zhou, Zhongxia
Liu, Huiqing
Liu, Xinyong
Based on crystallographic overlays of the known inhibitors TMC125 and R221239 complexed in RT, we designed a novel series of 4-phenoxy-6-(phenylamino) pyridin-2(1H)-one derivatives as HIV NNRTIs by molecular hybridization approach. The biological testing results indicated that 2-pyridone scaffold of these inhibitors was indispensable for their anti-HIV-1 activity, and substitution of halogen at the 3-position of the 2-pyridone ring would decrease the anti-HIV activity. Four most potent compounds had anti-HIV-1 IIIB activities at low micromolar concentrations (EC50 = 0.15-0.84 μM), comparable to that of nevirapine and delavidine. Some compounds were selected to test their anti-HIV-1 RT inhibitory action and to perform molecular modeling studies to predict the binding mode of these 2-pyridone derivatives.
View MoreContact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
Shanghai Demand Chemical Co., ltd,China
Contact:86-021-55237578/55239122
Address:Room 3H, No.578, Yingkou Road, Yangpu District, Shanghai, China
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
Doi:10.1016/j.saa.2013.12.102
(2014)Doi:10.1055/s-0034-1380384
(2015)Doi:10.1080/10426500490475166
(2004)Doi:10.1021/jm00036a016
(1994)Doi:10.1021/jm00014a008
(1995)Doi:10.1016/S0040-4020(01)85382-5
(1994)